The Duke Clinical Research Institute recently announced a partnership with biopharmaceutical company Bristol-Myers Squibb (BMS) to expand health data transparency by improving access to the company's clinical data.
According to BMS, the collaboration seeks to support the company's efforts to:

Broaden transparency; and
Use existing resources to improve public health and bolster scientific research.

The company will work with DCRI to screen researchers seeking access to the data and to ensure the integrity and consistency of the data.
This was reported by Health Data Management on July 7, 2014.
Contact information: Jennifer Fron Mauer, Executive Director, Corporate . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Market Watch

A snapshot of what’s happening across the industry—a one-stop source for key developments across policy and regulatory changes, service and treatment innovations, technological advancements, industry recognition and accreditation, mergers and acquisitions, leadership shifts, and more.

Filter Options

  • By Categories
  • By Date Range
  • Sort Date By
  • Results Per Page
Clear Filters

  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.